These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 11089976
1. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J. Nature; 2000 Nov 09; 408(6809):211-6. PubMed ID: 11089976 [Abstract] [Full Text] [Related]
2. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, Kwon KS. Oncogene; 2004 Nov 25; 23(55):8868-75. PubMed ID: 15480426 [Abstract] [Full Text] [Related]
3. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Li Y, Lu C, Xing G, Zhu Y, He F. Exp Cell Res; 2004 Nov 01; 300(2):379-87. PubMed ID: 15475002 [Abstract] [Full Text] [Related]
6. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J. Cell Signal; 2006 May 01; 18(5):688-703. PubMed ID: 16122907 [Abstract] [Full Text] [Related]
7. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity. Wang H, Sun X, Luo Y, Lin Z, Wu J. FEBS Lett; 2006 Oct 30; 580(25):6015-21. PubMed ID: 17052710 [Abstract] [Full Text] [Related]
11. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Tanaka Y, Kanai F, Ichimura T, Tateishi K, Asaoka Y, Guleng B, Jazag A, Ohta M, Imamura J, Ikenoue T, Ijichi H, Kawabe T, Isobe T, Omata M. Oncogene; 2006 Jan 26; 25(4):633-42. PubMed ID: 16247477 [Abstract] [Full Text] [Related]
13. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas. Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M. Clin Cancer Res; 2005 Jan 01; 11(1):259-66. PubMed ID: 15671554 [Abstract] [Full Text] [Related]
14. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress. Krysan K, Lou MF. Invest Ophthalmol Vis Sci; 2002 Jun 01; 43(6):1876-83. PubMed ID: 12036993 [Abstract] [Full Text] [Related]
18. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells. Supriatno, Harada K, Yoshida H, Sato M. Int J Oncol; 2005 Sep 01; 27(3):627-35. PubMed ID: 16077910 [Abstract] [Full Text] [Related]
20. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells. Adams DS, Hasson B, Boyer-Boiteau A, El-Khishin A, Shashoua VE. J Neurosci Res; 2003 May 01; 72(3):405-16. PubMed ID: 12692907 [Abstract] [Full Text] [Related] Page: [Next] [New Search]